Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sigilon Therapeutics Inc.

    NASDAQ: SGTX · Real-Time Price · USD
    22.47
    -0.59 (-2.56%)
    At close: Aug 10, 2023, 10:00 PM

    Sigilon Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 12.94M 9.6M
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 12.94M 9.6M
    Operating Income
    		 -43.67M -75.64M
    Interest Income
    		 946K 258K
    Pretax Income
    		 -43.56M -77.31M
    Net Income
    		 -43.46M -78.24M
    Selling & General & Admin
    		 18.98M 20.17M
    Research & Development
    		 37.63M 65.07M
    Other Expenses
    		 n/a 55K
    Operating Expenses
    		 56.61M 85.23M
    Interest Expense
    		 2.29M 1.99M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 56.61M 85.23M
    Income Tax Expense
    		 -105K 925K
    Shares Outstanding (Basic)
    		 32.41M 2.45M
    Shares Outstanding (Diluted)
    		 32.41M 2.45M
    EPS (Basic)
    		 -1.34 -31.92
    EPS (Diluted)
    		 -1.34 -31.92
    EBITDA
    		 -41.27M -75.32M
    EBIT
    		 -41.27M -75.32M
    Depreciation & Amortization
    		 2.4M 313K

    Add to Watchlist